V. Favrel

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

Jean Bourhis, Christian Sire, P. Gräff et al. · The Lancet Oncology · 2012 · 382 citations

Medicine, Oncology, Radiation Oncology +11

Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004–03

I. Toledano, P. Gräff, Antoine Serre et al. · Radiotherapy and Oncology · 2012 · 131 citations

Medicine, Oncology, Radiation Oncology +11

New targeted therapies in pituitary carcinoma resistant to temozolomide

Emmanuel Jouanneau, Anne Wierinckx, François Ducray et al. · Pituitary · 2011 · 111 citations

Medicine, Oncology, Pharmacology +12

Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?

O. Chapet, P. Romestaing, F. Mornex et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 50 citations

Medicine, Oncology, Surgery +16

Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement

S. Racadot, Mariette Mercier, Sophie Dussart et al. · Radiotherapy and Oncology · 2008 · 42 citations

Medicine, Oncology, Radiation Oncology +17